Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 696

1.

Letter to Editor Re: "Sudden Sensorineural Hearing Loss in the Department of Defense".

Sherlock S, Jack C.

Otolaryngol Head Neck Surg. 2018 Nov;159(5):941. doi: 10.1177/0194599818785161. No abstract available.

PMID:
30382007
2.

Hyperbaric oxygen treatment for the management of radiation-induced xerostomia.

Sherlock S, Way M, Tabah A.

J Med Imaging Radiat Oncol. 2018 Aug 16. doi: 10.1111/1754-9485.12789. [Epub ahead of print]

PMID:
30113763
3.

Audit of practice in Australasian hyperbaric units on the incidence of central nervous system oxygen toxicity.

Sherlock S, Way M, Tabah A.

Diving Hyperb Med. 2018 Jun 30;48(2):73-78. doi: 10.28920/dhm48.2.73-78.

PMID:
29888378
4.

Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients.

Maksymowych WP, Heijde DV, Baraliakos X, Deodhar A, Sherlock SP, Li D, Fleishaker D, Hendrikx T, Kanik KS.

Rheumatology (Oxford). 2018 Aug 1;57(8):1390-1399. doi: 10.1093/rheumatology/key104.

5.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF-06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects.

Bhattacharya I, Pawlak S, Marraffino S, Christensen J, Sherlock SP, Alvey C, Morris C, Arkin S, Binks M.

Clin Pharmacol Drug Dev. 2018 Jun;7(5):484-497. doi: 10.1002/cpdd.386. Epub 2017 Sep 7.

PMID:
28881472
6.

ECHM Consensus Conference and levels of evidence.

Sherlock S.

Diving Hyperb Med. 2017 Jun;47(2):133.

PMID:
28641328
7.

Development of an imaging mitigation strategy for patient enrolment in the tanezumab nerve growth factor inhibitor (NGF-ab) program with a focus on eligibility assessment.

Roemer FW, Miller CG, West CR, Brown MT, Sherlock SP, Kompel AJ, Diaz L, Galante N, Crema MD, Guermazi A.

Semin Arthritis Rheum. 2017 Dec;47(3):323-330. doi: 10.1016/j.semarthrit.2017.05.008. Epub 2017 May 20.

PMID:
28624172
8.

Hyperbaric oxygen therapy in the treatment of sudden sensorineural hearing loss: a retrospective analysis of outcomes.

Sherlock S, Thistlethwaite K, Khatun M, Perry C, Tabah A.

Diving Hyperb Med. 2016 Sep;46(3):160-165.

PMID:
27723017
9.

Inappropriate care in medicine.

Sherlock S.

Med J Aust. 2016 Feb 1;204(2):70-70e1. No abstract available.

PMID:
26821103
10.

Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, Odondi L, Metcalfe C, Owen-Smith A, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G.

Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310.

11.

No pain, no gain: depressed clients' experiences of cognitive behavioural therapy.

Barnes M, Sherlock S, Thomas L, Kessler D, Kuyken W, Owen-Smith A, Lewis G, Wiles N, Turner K.

Br J Clin Psychol. 2013 Nov;52(4):347-64. doi: 10.1111/bjc.12021. Epub 2013 Jul 17.

PMID:
24117909
13.

Near infrared imaging and photothermal ablation of vascular inflammation using single-walled carbon nanotubes.

Kosuge H, Sherlock SP, Kitagawa T, Dash R, Robinson JT, Dai H, McConnell MV.

J Am Heart Assoc. 2012 Dec;1(6):e002568. doi: 10.1161/JAHA.112.002568. Epub 2012 Dec 19.

14.

Control groups in hyperbaric trials.

Sherlock S.

Diving Hyperb Med. 2012 Sep;42(3):183. No abstract available.

PMID:
22987465
15.

Effect of survey instrument on participation in a follow-up study: a randomization study of a mailed questionnaire versus a computer-assisted telephone interview.

Rocheleau CM, Romitti PA, Sherlock SH, Sanderson WT, Bell EM, Druschel C.

BMC Public Health. 2012 Jul 31;12:579. doi: 10.1186/1471-2458-12-579.

16.

Graphite-coated magnetic nanoparticle microarray for few-cells enrichment and detection.

Chen Z, Hong G, Wang H, Welsher K, Tabakman SM, Sherlock SP, Robinson JT, Liang Y, Dai H.

ACS Nano. 2012 Feb 28;6(2):1094-101. doi: 10.1021/nn2034692. Epub 2012 Jan 17.

PMID:
22229344
17.

Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Nabukera SK, Romitti PA, Campbell KA, Meaney FJ, Caspers KM, Mathews KD, Sherlock SM, Puzhankara S, Cunniff C, Druschel CM, Pandya S, Matthews DJ, Ciafaloni E; MD STARnet.

J Child Neurol. 2012 Jun;27(6):734-40. doi: 10.1177/0883073811426501. Epub 2011 Dec 7.

18.

Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range.

Tabakman SM, Lau L, Robinson JT, Price J, Sherlock SP, Wang H, Zhang B, Chen Z, Tangsombatvisit S, Jarrell JA, Utz PJ, Dai H.

Nat Commun. 2011 Sep 13;2:466. doi: 10.1038/ncomms1477.

19.

High Performance In Vivo Near-IR (>1 μm) Imaging and Photothermal Cancer Therapy with Carbon Nanotubes.

Robinson JT, Welsher K, Tabakman SM, Sherlock SP, Wang H, Luong R, Dai H.

Nano Res. 2010 Oct 1;3(11):779-793.

20.

Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window.

Welsher K, Sherlock SP, Dai H.

Proc Natl Acad Sci U S A. 2011 May 31;108(22):8943-8. doi: 10.1073/pnas.1014501108. Epub 2011 May 16.

Supplemental Content

Loading ...
Support Center